Outcomes | During COVID-19 period (N = 60) | Before COVID-19 period (N = 76) | Univariable | Multivariable | |||
---|---|---|---|---|---|---|---|
variable | Odd ratioa (95% CI) | p-value | Adjusted ORc | p-value | |||
Primary outcome | |||||||
ED ROSC, N (%) | 16 (26.67) | 35 (46.05) | covid/ before covid period (base) | a0.43 (0.21–0.88) | 0.02 | c0.21 (0.08–0.53) | < 0.001 |
Secondary outcomes | |||||||
Survival to admission, N (%) | 15 (25.00) | 31 (40.79) | Covid / before covid period (base) | a0.48 (0.23–1.02) | 0.06 | c0.26 (0.10–0.67) | 0.005 |
30-day survival, N (%) | 2 (3.33) | 8 (10.53) | Covid / before covid period (base) | a0.29 (0.06,1.44) | 0.13 | c0.14 (0.02–1.28) | 0.08 |
30-day good CPC (Category 1–2), N (%) | 1(1.67) | 4(5.26) | Covid / before covid period (base) | a0.31 (0.03–2.80) | 0.29 | c0.24 (0.01- 4.10) | 0.33 |